Shanghai Pioneer Holding Crecimiento futuro
Future controles de criterios 0/6
Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Shanghai Pioneer Holding.
Información clave
n/a
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare | 21.1% |
| Tasa de crecimiento de los ingresos | n/a |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | None |
| Última actualización | n/a |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price
Jul 15
Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024
Apr 24Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024
Apr 03Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings
Apr 01Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks
Mar 22Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital
Feb 26Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?
Oct 21Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024
Sep 18Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024
Sep 01Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching
Aug 09Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year
Apr 14Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year
Mar 31Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly
Dec 15China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018
Sep 21China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year
Sep 02China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward
Jun 22China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064
Apr 14China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around
Jan 16These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely
Oct 11China Pioneer Pharma Holdings (HKG:1345) Is Paying Out Less In Dividends Than Last Year
Sep 15China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.056
Sep 01China Pioneer Pharma Holdings (HKG:1345) Will Be Looking To Turn Around Its Returns
Aug 26Returns On Capital At China Pioneer Pharma Holdings (HKG:1345) Paint A Concerning Picture
May 22We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt
Apr 25Can Mixed Financials Have A Negative Impact on China Pioneer Pharma Holdings Limited's 's (HKG:1345) Current Price Momentum?
Mar 14How Has China Pioneer Pharma Holdings (HKG:1345) Allocated Its Capital?
Feb 21
Should You Use China Pioneer Pharma Holdings' (HKG:1345) Statutory Earnings To Analyse It?
Feb 03Is China Pioneer Pharma Holdings Limited (HKG:1345) At Risk Of Cutting Its Dividend?
Jan 16China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet
Dec 29Is China Pioneer Pharma Holdings Limited's (HKG:1345) Stock Price Struggling As A Result Of Its Mixed Financials?
Dec 14China Pioneer Pharma Holdings (HKG:1345) Has Gifted Shareholders With A Fantastic 124% Total Return On Their Investment
Nov 29En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Shanghai Pioneer Holding no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.
Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 6/30/2024 | 1,648 | 164 | 55 | 124 | N/A |
| 3/31/2024 | 1,607 | 155 | -54 | 2 | N/A |
| 12/31/2023 | 1,567 | 146 | -163 | -119 | N/A |
| 9/30/2023 | 1,600 | 168 | -180 | -128 | N/A |
| 6/30/2023 | 1,634 | 190 | -198 | -137 | N/A |
| 3/31/2023 | 1,595 | 213 | -89 | -22 | N/A |
| 12/31/2022 | 1,556 | 235 | 19 | 93 | N/A |
| 9/30/2022 | 1,482 | 216 | 134 | 194 | N/A |
| 6/30/2022 | 1,408 | 196 | 250 | 296 | N/A |
| 3/31/2022 | 1,422 | 169 | 236 | 269 | N/A |
| 12/31/2021 | 1,435 | 143 | 222 | 242 | N/A |
| 9/30/2021 | 1,415 | 117 | 194 | 244 | N/A |
| 6/30/2021 | 1,395 | 91 | 166 | 246 | N/A |
| 3/31/2021 | 1,364 | 72 | 81 | 160 | N/A |
| 12/31/2020 | 1,332 | 52 | -4 | 74 | N/A |
| 9/30/2020 | 1,325 | 45 | -9 | 38 | N/A |
| 6/30/2020 | 1,318 | 37 | -15 | 2 | N/A |
| 3/31/2020 | 1,317 | 71 | 128 | 141 | N/A |
| 12/31/2019 | 1,316 | 105 | 272 | 281 | N/A |
| 9/30/2019 | 1,304 | 84 | 240 | 246 | N/A |
| 6/30/2019 | 1,293 | 63 | 208 | 212 | N/A |
| 3/31/2019 | 1,459 | 74 | 168 | 170 | N/A |
| 12/31/2018 | 1,624 | 85 | 128 | 129 | N/A |
| 9/30/2018 | 1,851 | 171 | 135 | 141 | N/A |
| 6/30/2018 | 2,077 | 258 | 142 | 153 | N/A |
| 3/31/2018 | 2,116 | 269 | N/A | 193 | N/A |
| 12/31/2017 | 2,154 | 279 | N/A | 234 | N/A |
| 9/30/2017 | 2,083 | 279 | N/A | 297 | N/A |
| 6/30/2017 | 2,012 | 280 | N/A | 361 | N/A |
| 3/31/2017 | 1,901 | 259 | N/A | 352 | N/A |
| 12/31/2016 | 1,790 | 237 | N/A | 342 | N/A |
| 9/30/2016 | 1,627 | 174 | N/A | 317 | N/A |
| 6/30/2016 | 1,464 | 111 | N/A | 292 | N/A |
| 3/31/2016 | 1,462 | 143 | N/A | 298 | N/A |
| 12/31/2015 | 1,461 | 174 | N/A | 305 | N/A |
| 9/30/2015 | 1,533 | 231 | N/A | 192 | N/A |
| 6/30/2015 | 1,605 | 287 | N/A | 79 | N/A |
| 3/31/2015 | 1,573 | 274 | N/A | 31 | N/A |
| 12/31/2014 | 1,540 | 262 | N/A | -18 | N/A |
| 9/30/2014 | 1,500 | 262 | N/A | -50 | N/A |
| 6/30/2014 | 1,460 | 263 | N/A | -82 | N/A |
| 3/31/2014 | 1,366 | 250 | N/A | -17 | N/A |
| 12/31/2013 | 1,272 | 238 | N/A | 48 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de 1345 es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de 1345 crezcan más rápidamente que el mercado Hong Kong
Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de 1345 crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de 1345 crezcan más rápidamente que el mercado de Hong Kong.
Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de 1345 crezcan a un ritmo superior a 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de 1345 se prevé que sea elevada dentro de 3 años.